Gut Liver.
2023 Sep;17(5):668-669. 10.5009/gnl230338.
Is Tegoprazan-Based Triple Therapy Effective in Regions with High Rates of Clarithromycin Resistance?
- Affiliations
-
- 1Department of Internal Medicine, Uijeongbu St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea
- KMID: 2546007
- DOI: http://doi.org/10.5009/gnl230338
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Efficacy and Tolerability of 14-Day Tegoprazan- versus Rabeprazole-Based Triple Therapy for Eradication of Helicobacter pylori: A Real-World Evidence Study
- Eradication Therapy for Helicobacter pylori with Diagnostic Test for Clarithromycin Resistance
- Comprehensive Analysis of Factors Associated With Helicobacter pylori Eradication Therapy
- Efficacy of Seven-Day Potassium-Competitive Acid Blocker-Based First-Line Helicobacter pylori Eradication Therapy Administered with Bismuth
- Ten-day tegoprazan-based concomitant therapy as a first-line treatment for Helicobacter pylori eradication
